KBC Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $59K | Hold |
5,072
| – | – | ﹤0.01% | 1526 |
|
2025
Q1 | $44K | Hold |
5,072
| – | – | ﹤0.01% | 1815 |
|
2024
Q4 | $73K | Buy |
5,072
+1,847
| +57% | +$26.6K | ﹤0.01% | 1717 |
|
2024
Q3 | $73K | Buy |
3,225
+902
| +39% | +$20.4K | ﹤0.01% | 1498 |
|
2024
Q2 | $45K | Hold |
2,323
| – | – | ﹤0.01% | 1682 |
|
2024
Q1 | $87K | Buy |
2,323
+473
| +26% | +$17.7K | ﹤0.01% | 1205 |
|
2023
Q4 | $104K | Hold |
1,850
| – | – | ﹤0.01% | 1052 |
|
2023
Q3 | $76K | Buy |
+1,850
| New | +$76K | ﹤0.01% | 1138 |
|
2022
Q4 | – | Sell |
-850
| Closed | -$24K | – | 1555 |
|
2022
Q3 | $24K | Hold |
850
| – | – | ﹤0.01% | 1501 |
|
2022
Q2 | $38K | Sell |
850
-5,272
| -86% | -$236K | ﹤0.01% | 1468 |
|
2022
Q1 | $466K | Hold |
6,122
| – | – | ﹤0.01% | 834 |
|
2021
Q4 | $912K | Buy |
6,122
+1,560
| +34% | +$232K | ﹤0.01% | 734 |
|
2021
Q3 | $664K | Sell |
4,562
-4,562
| -50% | -$664K | ﹤0.01% | 816 |
|
2021
Q2 | $1.79M | Hold |
9,124
| – | – | ﹤0.01% | 785 |
|
2021
Q1 | $1.65M | Hold |
9,124
| – | – | ﹤0.01% | 782 |
|
2020
Q4 | $7.11M | Buy |
+9,124
| New | +$7.11M | ﹤0.01% | 815 |
|